Company: BGLC
Filing Date: 2025-08-14
Form Type: NT 10-Q
Source: 0001477932-25-005903
Chunk: 0

Company: BioNexus Gene Lab Corp
Filing Date: 2025-08-14
Form: NT 10-Q
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

Notification Of Late Filing</div>

| ☐ | Form 10-K | ☐ | Form 20-F | ☐ | Form 11-K | ☒ | Form 10-Q | ☐ | Form 10-D | ☐ | Form N-SAR | ☐ | Form N-CSR |

For Period Ended: June 30, 2025

<div align='center'>PART I: REGISTRANT INFORMATION</div>

Full Name of Registrant: BioNexus Gene Lab Corp.

Address of Principal Executive Office:

<div align='center'>Unit A-28-7, Tower A, Menara UOA Bangsar,

No. 5 Jln Bangsar Utama 1,

59000 Kuala Lumpur</div>

<div align='center'>PART II: RULES 12b-25(b) AND (c)</div>

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b- 25(b), the following should be completed. (Check box if appropriate)

| ☒   | -a                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense |
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |                                                                                                                                   |
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                   |

<div align='center'>PART III: NARRATIVE</div>

The Company appointed a new Chief Financial Officer during the quarter ended June 30, 2025. The related transition of financial reporting responsibilities has required additional time to complete the preparation and review of the Company’s Quarterly Report on Form 10-Q. As a result, the Company is unable to file by the prescribed due date